Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-08 |
mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-07 |
mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-07 |
mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-07 |
mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |
mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-06 |
mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-06 |
mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.13 | 7e-06 |